Potent 2-[(pyrimidin-4-yl)amine}-1,3-thiazole-5-carbonitrile-based inhibitors of VEGFR-2 (KDR) kinaseJohn T. Sisko, George D. Hartman, Christine Fernandes et al.|Bioorganic & Medicinal Chemistry Letters|2005Cited by 35
A Novel Orally Bioavailable Inhibitor of Kinase Insert Domain-Containing Receptor Induces Antiangiogenic Effects and Prevents Tumor Growth <b> <i>in Vivo</i> </b>Laura Sepp‐Lorenzino, Kenneth A. Thomas, Elaine Rands et al.|Cancer Research|2004Cited by 26
INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITYChristopher R. Gibson, Thomas H. Rushmore, Charles C. Lin et al.|Drug Metabolism and Disposition|2005Cited by 6